Apyx Medical Corporation (APYX)
| Market Cap | 394.02M |
| Revenue (ttm) | 38.28M |
| Net Income (ttm) | -14.20M |
| Shares Out | 34.32M |
| EPS (ttm) | -0.41 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 156,693 |
| Open | 11.01 |
| Previous Close | 11.06 |
| Day's Range | 10.55 - 11.51 |
| 52-Week Range | 4.35 - 12.01 |
| Beta | 0.91 |
| Analysts | Buy |
| Price Target | 14.00 (+22.0%) |
| Est. Earnings Date | Nov 8, 2021 |
About APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to ac...
Financial Performance
In 2020, Apyx Medical's revenue was $27.71 million, a decrease of -1.86% compared to the previous year's $28.24 million. Losses were -$11.90 million, -39.63% less than in 2019.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for Apyx Medical stock is "Buy." The 12-month stock price forecast is 14.00, which is an increase of 21.95% from the latest price.
News
Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical Corporation Announces Appointment of Wendy Levine to the Company's Board of Directors
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical (APYX) Reports Q2 Loss, Tops Revenue Estimates
Apyx (APYX) delivered earnings and revenue surprises of 14.29% and 25.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical Corporation Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx (APYX) delivered earnings and revenue surprises of 0.00% and 9.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Analysts Estimate Apyx Medical (APYX) to Report a Decline in Earnings: What to Look Out for
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Apyx (APYX) delivered earnings and revenue surprises of 69.23% and 3.28%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Apyx Medical: Q4 Earnings Insights
Shares of Apyx Medical (NASDAQ:APYX) decreased 2.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 75.00% year over year to ($0.04), which beat th...
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Finan...
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical's Earnings: A Preview
Apyx Medical (NASDAQ:APYX) announces its next round of earnings this Wednesday, March 31. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.
Will Apyx Medical (APYX) Report Negative Earnings Next Week? What You Should Know
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apyx (APYX) Upgraded to Buy: What Does It Mean for the Stock?
Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 31, 2021
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical's (APYX) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Apyx Medical (APYX).
Here's Why Momentum Investors Will Love Apyx Medical (APYX)
Does Apyx Medical (APYX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Apyx (APYX) Upgraded to Buy: Here's Why
Apyx (APYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2020 Revenue Results
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx Medical Corporation to Participate in the ICR Conference 2021
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Ren...
Apyx (APYX) Upgraded to Buy: Here's What You Should Know
Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).